Dermatology Drugs for Children-US Food and Drug Administration Perspective

被引:0
作者
Epps, Roselyn E. [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Div Dermatol & Dent, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA
关键词
Pediatric drug development; Pediatric Research Equity Act (PREA); Best Pharmaceuticals for Children Act (BPCA);
D O I
10.1016/j.det.2022.02.004
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:289 / 296
页数:8
相关论文
共 16 条
  • [1] [Anonymous], HTTPSWWWACCESSDATAFD
  • [2] [Anonymous], Best Pharmaceutical's for Children Act (BPCA)
  • [3] [Anonymous], US FDA PEDIAT EXCLUS
  • [4] [Anonymous], HTTPSWWWFDAGOVREGULA
  • [5] [Anonymous], 1981, FDA CONSUM
  • [6] [Anonymous], PERC INFORM PAGE
  • [7] [Anonymous], HTTPSWWWFDAGOVINDUST
  • [8] [Anonymous], HTTPSC PATHORG
  • [9] [Anonymous], HTTPWWWFDAGOVDRUGSGU
  • [10] [Anonymous], HTTPSWWWGOVINFOGOVCO